CLINICAL_TRIALS
trial_result
· 2019-03-07
Clinical Trial Update: The Effects of LY2409021 on the Liver [Phase 1]
Summary
Phase 1 trial update assessing effects of LY2409021 on the liver in type 2 diabetes patients; study completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2019-03-07